Lovastatin and Niacin - Anthyperlipemic Combinations
Drug Name:
Lovastatin and Niacin - Anthyperlipemic Combinations
List Of Brands:
Indication Type Description:
Indication:
Hypercholesterolemia
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
FDC of Lovastatin 20mg + 20-12-2004
Niacin ER 500mg tablet
For Lipid lowering
Dosages/ Overdosage Etc:
Indication-
Hypercholesterolemia
Dosage-
Usual recommended dose - 500mg at bed time.
Niacin extended release tablets must be titrated and the dose must not increased beyond
500mg every 4 weeks up to a maxium dose of 2000mg/day